Dan Bradbury, Edward Kliphuis, Lana Ghanem
Dan Bradbury, Edward Kliphaus, and Lana Ghanem have joined the board of Biolinq, a San Diego-based firm developing a wirelessly enabled biosensor patch that would continuously monitor multiple biomarkers. Bradbury joins the board as executive chairman. He is the former CEO of Amylin Pharmaceuticals. Kliphuis is investment director of the New Businesses fund at M (Merck) Ventures. Ghanem is managing director of Hikma Ventures. M Ventures and Hikma were participants in Biolinq's financing round announced this week that brought in $10 million.